Danaher Corporation $DHR Shares Sold by Vancity Investment Management Ltd

Vancity Investment Management Ltd cut its holdings in shares of Danaher Corporation (NYSE:DHR) by 5.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 91,357 shares of the conglomerate’s stock after selling 5,212 shares during the period. Danaher accounts for about 2.6% of Vancity Investment Management Ltd’s holdings, making the stock its 11th biggest position. Vancity Investment Management Ltd’s holdings in Danaher were worth $17,402,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of DHR. California State Teachers Retirement System boosted its stake in shares of Danaher by 18,856.0% during the second quarter. California State Teachers Retirement System now owns 184,571,691 shares of the conglomerate’s stock worth $35,157,216,000 after buying an additional 183,598,005 shares during the period. BlackRock Inc. purchased a new stake in shares of Danaher in the second quarter valued at approximately $10,492,520,000. Norges Bank purchased a new stake in shares of Danaher during the 4th quarter worth $2,177,106,000. Jupiter Topco LLC purchased a new stake in shares of Danaher during the 2nd quarter worth $1,456,317,000. Finally, Generation Investment Management LLP acquired a new position in shares of Danaher during the 2nd quarter worth $1,287,949,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 0.1%

NYSE:DHR opened at $207.46 on Monday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The stock has a fifty day simple moving average of $201.74 and a 200-day simple moving average of $192.14. The company has a market capitalization of $145.84 billion, a PE ratio of 36.85, a price-to-earnings-growth ratio of 2.59 and a beta of 0.78.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period in the prior year, the company earned $0.77 EPS. The firm’s revenue was up 5.5% on a year-over-year basis. On average, equities research analysts expect that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently commented on the stock. TD Cowen reduced their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Evercore restated an “outperform” rating and set a $230.00 target price on shares of Danaher in a research report on Monday, July 6th. Wells Fargo & Company dropped their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday, July 22nd. Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. Finally, HSBC decreased their price target on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.